Cochrane Abstracts
Angiogenesis‐inhibitors for metastatic thyroid cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Angiogenesis‐inhibitors for Metastatic Thyroid Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436841/all/Angiogenesis‐inhibitors_for_metastatic_thyroid_cancer.
Angiogenesis‐inhibitors for metastatic thyroid cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436841/all/Angiogenesis‐inhibitors_for_metastatic_thyroid_cancer. Accessed January 20, 2026.
Angiogenesis‐inhibitors for metastatic thyroid cancer. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436841/all/Angiogenesis‐inhibitors_for_metastatic_thyroid_cancer
Angiogenesis‐inhibitors for Metastatic Thyroid Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436841/all/Angiogenesis‐inhibitors_for_metastatic_thyroid_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Angiogenesis‐inhibitors for metastatic thyroid cancer
ID - 436841
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436841/all/Angiogenesis‐inhibitors_for_metastatic_thyroid_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
